Yutaka Kanda

Comparison of cell lines for stable production of fucose‐negative antibodies with enhanced ADCC

Shinji Hosoi, Kazuya Yamano, Shigeru Iida, 2006, Biotechnology and bioengineering.

KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation.

Hiroshi Maeda, Yuko Sato, Yosuke Minami, 2009, Blood.

Design and synthesis of piperidine farnesyltransferase inhibitors with reduced glucuronidation potential.

Mitsunobu Hara, S. Soga, S. Akinaga, 2007, Bioorganic & medicinal chemistry.

Establishment of a GDP-mannose 4,6-dehydratase (GMD) knockout host cell line: a new strategy for generating completely non-fucosylated recombinant therapeutics.

Akira Okazaki, Shigeru Iida, Mitsuo Satoh, 2007, Journal of biotechnology.

Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.

Akira Okazaki, Mitsuo Satoh, M. Inoue, 2007, Glycobiology.

Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA.

Kazuya Yamano, Shigeru Iida, Mitsuo Satoh, 2004, Biotechnology and bioengineering.